Regeneron Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript
Great. Good morning. Thanks, everyone, for joining us. Really pleased to have the Regeneron team with us. We have Bob Landry, CFO; and we have Marion McCourt, Head of Commercial; and Ryan Crowe, Investor Relations. With that, Ryan, I'm going to turn it over to you.
Thanks Salveen. Great to be here. Just wanted to remind everyone that today's presentation will include forward-looking statements about Regeneron and actual results may differ materially from those presented in those forward-looking statements. A full recital of risks and uncertainties associated with Regeneron can be found in our SEC filings located on our website.
With that, over to Salveen.
Salveen, I was going to do some just introductory comments, kind of fill people in on where we've been in the first half of the year. As you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
